Americans’ prescription med use is declining

(HealthDay)—Bucking a longstanding upward trend, new data shows that the percentage of Americans taking any prescription drug has fallen slightly over the past decade. Still, nearly half—45.8%— of Americans said they took at least one prescription medicine over the past month, according to a national survey conducted in 2015-2016. That’s a slight dip from the 48.3% of Americans —children and […]

Continue reading »

Australian doctors overprescribing flu antivirals

Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, researchers from the University of Adelaide have found. The large study, published in BMJ Open, investigated the prescription of antibiotics and antivirals for the management of influenza-like […]

Continue reading »

Lack of access to antibiotics is a major global health challenge

Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, it is less well known that many people in low- and middle-income countries continue to die because they lack access to antibiotics. The majority of the world’s annual 5.7 million antibiotic-treatable […]

Continue reading »

Advanced breast cancer drug combo approved for NHS in England

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. The National Institute for Health and Care Excellence has recommended the drugs – called abemaciclib (Verzenio) and fulvestrant (Faslodex) – in new draft guidance, after the treatments were shown to slow disease progression and delay the need for chemotherapy in […]

Continue reading »

Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis

DUBLIN, March 12, 2019 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first patient in a Phase 2b/3 study of TD-1473 in patients with moderately to severely active ulcerative colitis. TD-1473 is a novel, orally administered and gut-selective pan-Janus kinase (JAK) inhibitor in clinical development as a treatment for multiple inflammatory […]

Continue reading »

Persistent, prolonged opioid use occurs after plastic surgery

(HealthDay)—Persistent and prolonged opioid use occur after plastic and reconstructive surgical procedures, according to a study published online March 7 in JAMA Facial Plastic Surgery. Cristen Olds, M.D., from the Stanford Hospital and Clinics in California, and colleagues conducted a population-based cohort study involving 466,677 patients who underwent five classes of plastic and reconstructive procedures between Jan. 1, 2007, and […]

Continue reading »

Study finds patient messages help predict medication adherence

Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence. But around half of these patients will for various reasons decide to discontinue these drugs early and face increased risk of recurrence. Looking for a means to […]

Continue reading »

BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin

NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it had a positive pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) regarding its lead asset, Plinabulin. The focus of this meeting was the content of the chemistry, […]

Continue reading »